Enterococcus: Difference between revisions

From IDWiki
Enterococcus
No edit summary
()
Line 1: Line 1:
   
== Background ==
+
==Background==
   
=== Microbiology ===
+
===Microbiology===
* Facultative anaerobic, non-spore-forming, [[Hemolysis pattern::α-hemolytic|alpha-]] or [[Hemolysis pattern::γ-hemolytic|gamma-hemolytic]], [[Catalase test::catalase-negative]], [[Stain::Gram-positive]] [[Cellular shape::cocci]]
 
* Grows on bile esculin agar
 
* Most are Lancefield group D
 
* Commensal gut flora
 
* Increasing antibiotic resistance
 
   
 
*Facultative anaerobic, non-spore-forming, [[Hemolysis pattern::α-hemolytic|alpha-]] or [[Hemolysis pattern::γ-hemolytic|gamma-hemolytic]], [[Catalase test::catalase-negative]], [[Stain::Gram-positive]] [[Cellular shape::cocci]]
=== Species ===
 
 
*Grows on bile esculin agar
* ''E. faecalis''
 
  +
*[[PYR test|PYR]] positive
** More common (90-95%)
 
 
*Most are Lancefield group D
** More commonly genitourinary source
 
 
*Commensal gut flora
** More susceptible to antibiotics
 
 
*Increasing antibiotic resistance
* ''E. faecium''
 
** Less common (5-10%)
 
** More commonly gastrointestinal source
 
** Less susceptible to antibiotics
 
** Most common VRE
 
* ''E. gallinarum''
 
* ''E. casseliflavus''
 
   
=== Vacomycin Resistance ===
+
===Species===
* Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis
 
* '''VanA''': most common. Mutation to d-Ala-d-Lac, leading to high resistance to glycopeptides.
 
* '''VanB''': more common in ''E. faecium'' in Australia
 
* '''VanC''': chromosomal resistance on ''E. gallinarum'' and ''E. casseliflavus''
 
   
 
*''E. faecalis''
== Management ==
 
 
**More common (90-95%)
=== VRE ===
 
 
**More commonly genitourinary source
* [[Is treated by::Daptomycin]], [[Is treated by::doxycycline]], [[Is treated by::linezolid]], [[Is treated by::tedizolid]], [[Is treated by::oritavancin]], [[Is treated by::quinupristin-dalfopristin]] (for ''E. faecium'')
 
 
**More susceptible to antibiotics
 
*''E. faecium''
 
**Less common (5-10%)
 
**More commonly gastrointestinal source
 
**Less susceptible to antibiotics
 
**Most common VRE
 
*''E. gallinarum''
 
*''E. casseliflavus''
  +
  +
===Vacomycin Resistance===
  +
 
*Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis
 
*'''VanA''': most common. Mutation to d-Ala-d-Lac, leading to high resistance to glycopeptides.
 
*'''VanB''': more common in ''E. faecium'' in Australia
 
*'''VanC''': chromosomal resistance on ''E. gallinarum'' and ''E. casseliflavus''
  +
 
==Management==
 
===VRE===
  +
 
*[[Is treated by::Daptomycin]], [[Is treated by::doxycycline]], [[Is treated by::linezolid]], [[Is treated by::tedizolid]], [[Is treated by::oritavancin]], [[Is treated by::quinupristin-dalfopristin]] (for ''E. faecium'')
   
 
{{DISPLAYTITLE:''Enterococcus'' species}}
 
{{DISPLAYTITLE:''Enterococcus'' species}}

Revision as of 09:17, 17 August 2020

Background

Microbiology

  • Facultative anaerobic, non-spore-forming, alpha- or gamma-hemolytic, catalase-negative, Gram-positive cocci"cocci" is not in the list (coccus, bacillus, coccobacillus, diplococcus, spirochete, curved, pleomorphic, yeast, mold) of allowed values for the "Shape" property.
  • Grows on bile esculin agar
  • PYR positive
  • Most are Lancefield group D
  • Commensal gut flora
  • Increasing antibiotic resistance

Species

  • E. faecalis
    • More common (90-95%)
    • More commonly genitourinary source
    • More susceptible to antibiotics
  • E. faecium
    • Less common (5-10%)
    • More commonly gastrointestinal source
    • Less susceptible to antibiotics
    • Most common VRE
  • E. gallinarum
  • E. casseliflavus

Vacomycin Resistance

  • Vancomycin binds to d-Ala-d-Ala pentapeptids, interfering with cell wall synthesis
  • VanA: most common. Mutation to d-Ala-d-Lac, leading to high resistance to glycopeptides.
  • VanB: more common in E. faecium in Australia
  • VanC: chromosomal resistance on E. gallinarum and E. casseliflavus

Management

VRE

References

  1. ^  James H. Jorgensen, Sharon A. Crawford, Cynthia C. Kelly, Jan E. Patterson. In VitroActivity of Daptomycin against Vancomycin-Resistant Enterococci ofVarious Van Types and Comparison of Susceptibility TestingMethods. Antimicrobial Agents and Chemotherapy. 2003;47(12):3760-3763. doi:10.1128/aac.47.12.3760-3763.2003.